Diabetes and insulin in regulation of brain cholesterol metabolism

Ryo Suzuki, Kevin Lee, Enxuan Jing, Sudha B. Biddinger, Jeffrey G. McDonald, Thomas J. Montine, Suzanne Craft, C. Ronald Kahn

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

The brain is the most cholesterol-rich organ in the body, most of which comes from in situ synthesis. Here we demonstrate that in insulin-deficient diabetic mice, there is a reduction in expression of the major transcriptional regulator of cholesterol metabolism, SREBP-2, and its downstream genes in the hypothalamus and other areas of the brain, leading to a reduction in brain cholesterol synthesis and synaptosomal cholesterol content. These changes are due, at least in part, to direct effects of insulin to regulate these genes in neurons and glial cells and can be corrected by intracerebroventricular injections of insulin. Knockdown of SREBP-2 in cultured neurons causes a decrease in markers of synapse formation and reduction of SREBP-2 in the hypothalamus of mice using shRNA results in increased feeding and weight gain. Thus, insulin and diabetes can alter brain cholesterol metabolism, and this may play an important role in the neurologic and metabolic dysfunction observed in diabetes and other disease states.

Original languageEnglish (US)
Pages (from-to)567-579
Number of pages13
JournalCell Metabolism
Volume12
Issue number6
DOIs
StatePublished - Dec 1 2010

Fingerprint

Cholesterol
Insulin
Brain
Hypothalamus
Neurons
Neurologic Manifestations
Neuroglia
Synapses
Small Interfering RNA
Genes
Weight Gain
Injections

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

Suzuki, R., Lee, K., Jing, E., Biddinger, S. B., McDonald, J. G., Montine, T. J., ... Kahn, C. R. (2010). Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metabolism, 12(6), 567-579. https://doi.org/10.1016/j.cmet.2010.11.006

Diabetes and insulin in regulation of brain cholesterol metabolism. / Suzuki, Ryo; Lee, Kevin; Jing, Enxuan; Biddinger, Sudha B.; McDonald, Jeffrey G.; Montine, Thomas J.; Craft, Suzanne; Kahn, C. Ronald.

In: Cell Metabolism, Vol. 12, No. 6, 01.12.2010, p. 567-579.

Research output: Contribution to journalArticle

Suzuki, R, Lee, K, Jing, E, Biddinger, SB, McDonald, JG, Montine, TJ, Craft, S & Kahn, CR 2010, 'Diabetes and insulin in regulation of brain cholesterol metabolism', Cell Metabolism, vol. 12, no. 6, pp. 567-579. https://doi.org/10.1016/j.cmet.2010.11.006
Suzuki, Ryo ; Lee, Kevin ; Jing, Enxuan ; Biddinger, Sudha B. ; McDonald, Jeffrey G. ; Montine, Thomas J. ; Craft, Suzanne ; Kahn, C. Ronald. / Diabetes and insulin in regulation of brain cholesterol metabolism. In: Cell Metabolism. 2010 ; Vol. 12, No. 6. pp. 567-579.
@article{59756d4b6753430fac7b02048956adfd,
title = "Diabetes and insulin in regulation of brain cholesterol metabolism",
abstract = "The brain is the most cholesterol-rich organ in the body, most of which comes from in situ synthesis. Here we demonstrate that in insulin-deficient diabetic mice, there is a reduction in expression of the major transcriptional regulator of cholesterol metabolism, SREBP-2, and its downstream genes in the hypothalamus and other areas of the brain, leading to a reduction in brain cholesterol synthesis and synaptosomal cholesterol content. These changes are due, at least in part, to direct effects of insulin to regulate these genes in neurons and glial cells and can be corrected by intracerebroventricular injections of insulin. Knockdown of SREBP-2 in cultured neurons causes a decrease in markers of synapse formation and reduction of SREBP-2 in the hypothalamus of mice using shRNA results in increased feeding and weight gain. Thus, insulin and diabetes can alter brain cholesterol metabolism, and this may play an important role in the neurologic and metabolic dysfunction observed in diabetes and other disease states.",
author = "Ryo Suzuki and Kevin Lee and Enxuan Jing and Biddinger, {Sudha B.} and McDonald, {Jeffrey G.} and Montine, {Thomas J.} and Suzanne Craft and Kahn, {C. Ronald}",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/j.cmet.2010.11.006",
language = "English (US)",
volume = "12",
pages = "567--579",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Diabetes and insulin in regulation of brain cholesterol metabolism

AU - Suzuki, Ryo

AU - Lee, Kevin

AU - Jing, Enxuan

AU - Biddinger, Sudha B.

AU - McDonald, Jeffrey G.

AU - Montine, Thomas J.

AU - Craft, Suzanne

AU - Kahn, C. Ronald

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The brain is the most cholesterol-rich organ in the body, most of which comes from in situ synthesis. Here we demonstrate that in insulin-deficient diabetic mice, there is a reduction in expression of the major transcriptional regulator of cholesterol metabolism, SREBP-2, and its downstream genes in the hypothalamus and other areas of the brain, leading to a reduction in brain cholesterol synthesis and synaptosomal cholesterol content. These changes are due, at least in part, to direct effects of insulin to regulate these genes in neurons and glial cells and can be corrected by intracerebroventricular injections of insulin. Knockdown of SREBP-2 in cultured neurons causes a decrease in markers of synapse formation and reduction of SREBP-2 in the hypothalamus of mice using shRNA results in increased feeding and weight gain. Thus, insulin and diabetes can alter brain cholesterol metabolism, and this may play an important role in the neurologic and metabolic dysfunction observed in diabetes and other disease states.

AB - The brain is the most cholesterol-rich organ in the body, most of which comes from in situ synthesis. Here we demonstrate that in insulin-deficient diabetic mice, there is a reduction in expression of the major transcriptional regulator of cholesterol metabolism, SREBP-2, and its downstream genes in the hypothalamus and other areas of the brain, leading to a reduction in brain cholesterol synthesis and synaptosomal cholesterol content. These changes are due, at least in part, to direct effects of insulin to regulate these genes in neurons and glial cells and can be corrected by intracerebroventricular injections of insulin. Knockdown of SREBP-2 in cultured neurons causes a decrease in markers of synapse formation and reduction of SREBP-2 in the hypothalamus of mice using shRNA results in increased feeding and weight gain. Thus, insulin and diabetes can alter brain cholesterol metabolism, and this may play an important role in the neurologic and metabolic dysfunction observed in diabetes and other disease states.

UR - http://www.scopus.com/inward/record.url?scp=78649513976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649513976&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2010.11.006

DO - 10.1016/j.cmet.2010.11.006

M3 - Article

VL - 12

SP - 567

EP - 579

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 6

ER -